drugset / Trial / NCT02253004

Induction of Migraine Aura With Cilostazol

NCT02253004

Phase 0 Completed 16 enrolled Herlev Hospital
RandomizedCrossoverQuadruple-blindBasic science

Summary

In a double blind placebo-controlled cross-over study the effect of cilostazol on aura induction and endothelial response is tested in patient with migraine with aura.

Timeline

Start
2014-09
Primary completion
2015-08
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Cilostazol Small molecule 200 mg Oral